Gadobutrol Injection — FDA Drug Shortage

To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.

The FDA lists a drug shortage record for Gadobutrol Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status To Be Discontinued. The shortage was first posted on Jun 30, 2026.

Shortage details

Status
To Be Discontinued
Company
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Package NDC
65219-281-07
Dosage Form
Injection
Presentation
Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07)
Initial Posting
Jun 30, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.